NSC |
Compound |
Enrichment |
Correlation |
NSC 682996 |
Null |
0.035202825328704 |
0.49687324 |
NSC 685285 |
Null |
0.035202825328704 |
0.0070166503 |
NSC 686554 |
9H-Quino[4,3,2-de][1,10]phenanthrolin-9-one, 2-(2-pyridinyl)- |
0.035202825328704 |
0.35711652 |
NSC 716503 |
Null |
0.035202825328704 |
0.12086525 |
NSC 719667 |
7-methoxy-8-[3-(1,4-oxazinan-4-yl)propoxy-(11aS)-2,3,5,11a -tetrahydro-1H-pyrrolo[2,1-c][1,4]benzodiazepine-5-one |
0.035202825328704 |
0.4085822 |
NSC 720320 |
1,6-bis-(2,6-difluorobenzyl)-2-(2,6-difluorophenyl)-5-methoxy-benzimidazole |
0.035202825328704 |
-0.039858354 |
NSC 725098 |
Null |
0.035202825328704 |
0.34030403 |
NSC 726217 |
Combretastatin A4-analogue |
0.035202825328704 |
0.24612937 |
NSC 731704 |
1-[4-Ethoxycarbonyl)homopiperazine-1-yl]diazen-1-ium-1,2-dio late. |
0.0352028253287042 |
0.34916022 |
NSC 732205 |
Null |
0.0352028253287042 |
0.64481495 |